Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

LKFT holding history

Lakefront Biotherapeutics NV in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LKFT overviewAll 13F holders of LKFTFull Q2 2026 holdings

Shares (Q2 2026)
197,844
Value
$5.93M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of LKFT by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026197,844$5.93M<0.1%−17,874−8.3%ReducedHolders
Q1 2026215,718$6.47M<0.1%−59,281−21.6%ReducedHolders
Q4 2025274,999$8.99M<0.1%+73,830+36.7%AddedHolders
Q3 2025201,169$6.97M<0.1%+47,984+31.3%AddedHolders
Q2 2025153,185$4.29M<0.1%+90,165+143.1%AddedHolders
Q1 202563,020$1.58M<0.1%+63,020NewHolders
Q3 20240$00.0%−16,780−100.0%Sold outHolders
Q2 202416,780$415.8K<0.1%−34,893−67.5%ReducedHolders
Q1 202451,673$1.66M<0.1%−23,967−31.7%ReducedHolders
Q4 202375,640$3.07M<0.1%+18,295+31.9%AddedHolders
Q3 202357,345$1.98M<0.1%+40,798+246.6%AddedHolders
Q2 202316,547$672.8K<0.1%+16,547NewHolders
Q1 20230$00.0%−59,996−100.0%Sold outHolders
Q4 202259,996$2.66M<0.1%−66,138−52.4%ReducedHolders
Q3 2022126,134$5.38M<0.1%+5,411+4.5%AddedHolders
Q2 2022120,723$6.74M<0.1%+77,508+179.4%AddedHolders
Q1 202243,215$2.68M<0.1%−94,125−68.5%ReducedHolders
Q4 2021137,340$7.57M<0.1%+539+0.4%AddedHolders
Q3 2021136,801$7.20M<0.1%+69,710+103.9%AddedHolders
Q2 202167,091$4.62M<0.1%+62,719+1,434.6%AddedHolders
Q1 20214,372$337.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.